Navigation Links
BioSpecifics Technologies Corp. to Present at Cowen and Company 29th Annual Health Care Conference
Date:3/10/2009

LYNBROOK, N.Y., March 10 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Tom Wegman, will present a corporate overview at the upcoming Cowen and Company 29th Annual Health Care Conference on Tuesday, March 17, 2009, at 9:30am ET at the Boston Marriott Copley Place in Boston, MA. A live webcast of the presentation can be accessed at www.biospecifics.com ("Future Company Presentation March 17, 2009"). The presentation will be archived for 90 days.

About BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for three clinical indications: Dupuytren's disease; Peyronie's disease; and frozen shoulder (adhesive capsulitis). Its strategic partner Auxilium Pharmaceuticals, Inc. has filed a Biologic License Application with the U.S. Food and Drug Administration to market injectable collagenase (XIAFLEX(TM)) in the U.S. for the treatment of Dupuytren's disease, while Pfizer, Inc. is responsible for commercialization of XIAFLEX(TM) in Europe and other territories.


'/>"/>
SOURCE BioSpecifics Technologies Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronies Disease
2. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
3. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
4. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
5. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
6. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
7. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
8. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
9. Senesco Technologies Initiates Preclinical Studies for Cancer Target
10. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
11. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014 InformEx, North America,s leading ... will hold the 30 th edition of its annual ... Center from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... fine chemical and specialty chemical companies will take part in ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a LifeCentre ... Leesburg, Virginia is the first in Loudoun ... Dr. Susan M. Barnes , Medical Director, ... and husband, Dr. Cole Taylor , are avid scuba divers. ...
(Date:1/14/2014)... January 14, 2014 Equashield ( ... hazardous drugs, today announced that it has achieved ... year.   Equashield,s closed systems reduce ... nurses and other medical professionals who prepare and ...
Breaking Medicine Technology:Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Equashield's Sales Grow by 60% in 2013 2
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
(Date:4/22/2014)... A recently FDA-approved device has been shown to ... much as 50 percent. When coupled with an innovative ... the device facilitated the complete elimination of seizures in ... the decade-long clinical trials. , That,s good news for ... the U.S. living with epilepsy whose seizures can,t be ...
(Date:4/22/2014)... 2014 Researchers at UT Southwestern Medical Center are ... depression . , A team of physician-scientists at ... ghrelin (a hormone with natural anti-depressant properties) works inside ... new treatment for depression in the form of a ... study, published online in April,s issue of Molecular ...
(Date:4/22/2014)... April 22, 2014: The Association for Molecular Pathology ... Journal of Molecular Diagnostics on recommendations for ... and master,s levels of education. The report was ... Task Force of the AMP Training and Education ... need of educating future medical laboratory scientists appropriately ...
Breaking Medicine News(10 mins):Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 3Health News:AMP publishes curriculum recommendations for medical laboratory scientists 2
... Health Organization director-general Dr. Lee Jong-wook dies on 23rd of ... blood clot in his brain//. He was undergoing an emergency ... 61 years old suffered from discomfort while attending an official ... Switzerland for further treatment. ,Lee became WHO director-general ...
... and Women's Hospital (RBWH), Sydney struggles with an outbreak ... wards were found with a bacterium called ... ,To prevent the spread, 12 patients from burns ... were shifted to Sydney hospital and some to Brisbane's ...
... The Union Government may go in for an immunisation campaign ... of measles vaccine. // ,Though the measles vaccines ... the government wants to ensure full coverage through an additional ... told PTI., ,The campaign would commence soon after completion ...
... found that Invitro Fertilization (IVF) resulted in an increase ... is found// that the complication risk is about 16 ... praevia is the common complication found associated with the ... the entire cervix, blocking a baby's passage into the ...
... medical students and doctors participated in a rally held ... at the Deputy Commissioner's office//. The participants were from ... College, and junior doctors. The significance of the rally ... regarding the reservation of 27 % of seats in ...
... popular belief that people who have suffered from hardships early ... a new study reports// that they in reality become more ... gullible adults; this was the finding of a new study ... people who suffered from troubled upbringing during childhood did not ...
Cached Medicine News:
System, English (Continental cord), 230 VAC....
Micro-mini fiber optic light....
The Twin Beam lightsource is a standard light source. The Twin Beam contains two 150W, DNF lamps, one primary lamp, the other to serve as a built-in spare lamp. This allows rapid change to the spare ...
Xenon technology achieves a higher efficiency than halogen light sources. Consequently they provide more light....
Medicine Products: